Salesforce
CRM
Apple
AAPL
Meta Platforms
META
4
Disney
DIS
5
Alibaba
BABA
Ascendiant Capital Maintains Buy on NovaBay Pharmaceuticals, Adjusts Price Target To $0.85 (1-35 Reverse Stock Split)
Ladenburg Thalmann Maintains Buy on NovaBay Pharmaceuticals, Lowers Price Target to $3.8